Hyperplasia: all 883 studies
Page 7 of 9. Open to participants first (97), then studies with results posted, then the rest; newest registration first within each.
- Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 GramsStatus unknownNCT02167009Not applicable
- Quantitative Real-time Ultrasound Elastography for Characterisation of Liver TumorsCompletedNCT02156700
- Study to Assess the Efficacy of Medi-Tate iTind DeviceCompletedNCT02145208Not applicable
- PERmixon® in LUTS Evaluation Study (PERLES)CompletedNCT02121613Phase 4
- Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionTerminatedNCT02109224Phase 1
- Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic HyperplasiaCompletedNCT02106182Phase 4
- Women With Asymptomatic Endometrial HyperplasiaCompletedNCT02100137
- Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal DysplasiaCompletedNCT02099552
- Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal HyperplasiaCompletedNCT02096510Phase 1/2
- KTP Green Light Prostatectomy Compared With TUR-P in High Risk PatientsActive, not recruitingNCT02075736Not applicable
- Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic HyperplasiaCompletedNCT02074644Not applicable
- Storage Symptom After Laser ProstatectomyStatus unknownNCT02073799
- KTP Green Light Prostatectomy Compared With Open ProstatectomyCompletedNCT02072499Phase 4
- Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal MicrobiomeCompletedNCT02063919
- Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic HyperplasiaCompletedNCT02054013Not applicable
- Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot StudyCompletedNCT02051036Not applicable
- A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate HyperplasiaCompletedNCT02038868Phase 2
- The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic HyperplasiaStatus unknownNCT02033798Not applicable
- Functional Changes of Urogenital System After Holmium Laser ProstatectomyStatus unknownNCT02033785
- Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular SystemCompletedNCT02029560
- Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)Status unknownNCT02021032Phase 4
- Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization ElectrodeTerminatedNCT02019030
- KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)CompletedNCT02011308Not applicable
- Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized PatientsStatus unknownNCT02006303Phase 4
- Study of Esophageal Squamous Dysplasia Prevalence at Tenwek HospitalCompletedNCT01981876
- Pilot Study of Curcumin for Women With Obesity and High Risk for Breast CancerCompletedNCT01975363Not applicable
- Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood DyscrasiaCompletedNCT01974401Phase 2
- Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile DysfunctionWithdrawnNCT01967251Phase 2
- Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPHCompletedNCT01966614Phase 3
- Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.CompletedNCT01963312Not applicable
- OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and CancerCompletedNCT01961102
- To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of ProstateCompletedNCT01958892
- This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood SamplesCompletedNCT01957189Phase 1
- Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large ProstatesCompletedNCT01952912Not applicable
- Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial CancerWithdrawnNCT01943058Phase 2
- Safety and Pharmacokinetic Interaction Study of Tadalafil and DutasterideCompletedNCT01942551Phase 1
- Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaCompletedNCT01939184Phase 2
- Pathophysiological Mechanisms of Fibromuscular DysplasiaCompletedNCT01935752Not applicable
- Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment.TerminatedNCT01931605Phase 3
- Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)CompletedNCT01925586
- Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaCompletedNCT01922375Phase 4
- Endoscopic Sub-mucosal Dissection With the Nestis® Jet Injector System With a Bi-functional Catheter: First Prospective TrialCompletedNCT01913223Not applicable
- Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)TerminatedNCT01896973Not applicable
- The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly PatientsCompletedNCT01892332Not applicable
- 2013 Annual National Digital Rectal Exam (DRE) Day StudyCompletedNCT01886547
- Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and ComplicationsStatus unknownNCT01876836Phase 4
- Decision Support for Parents Receiving Information About Child's Rare DiseaseCompletedNCT01875640
- Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerCompletedNCT01874184Not applicable
- Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.Status unknownNCT01862380Not applicable
- Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.Status unknownNCT01861041Phase 4
- Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)CompletedNCT01846793Phase 3
- Prostatic Artery Embolization for Benign Prostatic HyperplasiaCompletedNCT01835860Phase 2/3
- JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)TerminatedNCT01830829Phase 3
- PK Comparison of GL2701 With Finasteride and Tamsulosin in CombinationCompletedNCT01829893Phase 1
- Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy OutcomeCompletedNCT01826617
- Ultrasound Screening for Developmental Dysplasia of the Hip in NewbornsCompletedNCT01818934Not applicable
- A French Non Interventional Multicentric Cohort Study in Patients With Colorectal DysplasiaActive, not recruitingNCT01816438
- CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic EndotheliumCompletedNCT01808729
- Cardiovascular Risk Profile in Patients With Congenital Adrenal HyperplasiaCompletedNCT01807364
- Clinical Management of Childhood Intestinal Lymphoid Nodular HyperplasiaStatus unknownNCT01789294Phase 4
- Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic HyperplasiaCompletedNCT01781117Not applicable
- Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of PrematurityCompletedNCT01780155
- Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)WithdrawnNCT01775488Not applicable
- Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)CompletedNCT01775462Phase 2
- Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal HyperplasiaStatus unknownNCT01771328Phase 2
- WEUSKOP5723: Prostate Cancer StudyCompletedNCT01767363
- Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk FactorsCompletedNCT01764542Not applicable
- Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic HyperplasiaCompletedNCT01757769Phase 4
- Early Diagnosis of Oral Cancer by Detecting p16 MethylationCompletedNCT01695018
- Improving the Treatment for Women With Early Stage Cancer of the UterusActive, not recruitingNCT01686126Phase 2
- Metformin for the Treatment of Endometrial HyperplasiaCompletedNCT01685762Early Phase 1
- Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block DurationCompletedNCT01675895Phase 4
- Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative StudyCompletedNCT01665586Not applicable
- Anal Dysplasia Study of Men Who Have Sex With Men Living With HIVWithdrawnNCT01663558Phase 4
- Bioequivalence - Duodart Against Avodart & OmnicCompletedNCT01657851Phase 1
- Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary DysplasiaActive, not recruitingNCT01632475
- Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional StatusCompletedNCT01629940
- Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)CompletedNCT01629927
- Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of ProstateCompletedNCT01627522Phase 2/3
- Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)CompletedNCT01604811Phase 4
- Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single SurgeonCompletedNCT01604148
- Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male SubjectsCompletedNCT01577693Phase 1
- Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical TherapyCompletedNCT01566292Phase 2/3
- QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser)CompletedNCT01534793
- BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)WithdrawnNCT01520441Early Phase 1
- Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal WomenCompletedNCT01499602Not applicable
- A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East AsiaCompletedNCT01495026Phase 1
- Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)CompletedNCT01494337Phase 4
- Clinical Evaluation of NeoPlex4 Assay and NeoPlex SystemCompletedNCT01488721
- The Role of microRNAs in Organ Remodeling in Lower Urinary Tract DysfunctionCompletedNCT01482676
- Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.CompletedNCT01471678Phase 1
- Electronic Catheter StethoscopeCompletedNCT01463462
- Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT01454349Phase 1/2
- Ascorbyl Peroxide Association With Bronchopulmonary DysplasiaCompletedNCT01439295
- Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)CompletedNCT01438775Phase 3
- Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate HyperplasiaCompletedNCT01436877Not applicable
- Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary HyperparathyroidismWithdrawnNCT01421407Not applicable
- Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)Status unknownNCT01404637Not applicable
- X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction SurveyCompletedNCT01398813
- Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical PhenotypeCompletedNCT01398397